Terms & conditions
Neuron on the media
Associations and Fundations
SHAREHOLDERS AND INVESTORS
Neuron BPh attends the first MAB meeting
Press release 24 Nov 2010 IV ANCES National Awards Neuron BPh has been awarded the first prize for “Business growth of a biotech company”
Federico Mayor Zaragoza becomes a member of the Scientific Advisory Board of Neuron BPh
Neuron BPh is awarded an IDEAL 2009 prize
Neuron BPh and INNOFOOD are set to extract neuroprotective and antioxidant agents from the by-products of fruit such as mangos, custard apples and avocados.
Neuron BPh patents a new compound designed as a potential treatment for Alzheimer’s disease. This is the second molecule developed completely by Spanish scientists at Neuron BPh to combat this disease.
Neuron BPh in BIOSPAIN 2010
Neuron BPh and Ferrer sign a framework agreement for the future development of joint projects.
Neuron BPh patents a new compound as a potential treatment for Alzheimer’s disease
Patent granted to Neuron BPh
Neuron BPh awarded the prize for the best innovative European company
Neuron BPH joins the market in the MAB
Neuron BPh receives recognition as an innovative technological company.
Favourable report from MAB with regard to the admission of Neuron Biopharma to the growth companies sector.
Repsol and Neuron BPh sign an agreement
The Spanish savings bank CajaGranada becomes a shareholder of the biotechnology company Neuron BPh
Neuron BPh signs a co-operative agreement with the Universidad de Granada and allocates the university a share assignment
Neuron BPh is awarded the Flag of Andalucia
The Minister for Innovation, Science and Industry, Cristina Garmendia, visits the facilities of the biotechnology company Neuron BPh at the Health-Science Technology Park in Granada
Neuron Bio |